ClinConnect ClinConnect Logo
Search / Trial NCT01244256

Efficacy and Comparative of the Association Beclomethasone Clotrimzaol + Gentamicin in Patients With Acne Contaminated

Launched by AZIDUS BRASIL · Nov 18, 2010

Trial Information

Current as of April 28, 2025

Suspended

Keywords

ClinConnect Summary

The specific objective is to evaluate, by means of analytical propedeutics medical improvement in clinical signs and symptoms related to acne infected, the use of the association: Clotrimazole, Gentamicin and Beclomethasone versus association: Clotrimazole and Gentamicin, which will first be randomized.

The study should be conducted with 20 research subjects aged over 18 years, of both sexes, showing the framework of bilateral lesions infected with acne, at any stage of evolution. The study subjects will receive treatment with both products, so they can use one in each lesion chosen at ran...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Subject search of both sexes, regardless of color or social class
  • From age to 18, with good mental health
  • Carriers of two outbreaks of acne contaminated
  • Subjects who agree to return follow-up visits
  • Research subjects who agree to participate and sign the Deed of Consent
  • Exclusion Criteria:
  • Subject Research carriers of susceptibility to gentamicin
  • Research subjects suffering from sensitivity to clotrimazole
  • Research subjects suffering from sensitivity to beclomethasone
  • Research subjects who are making use of steroids or steroidal anti-inflammatory and non-steroidal drugs or who made use of topical or oral 15 days ago
  • Research subjects who are doing immunosuppressive treatment
  • Research subjects with a diagnosis of eosinophilic folliculitis or Pseudo-folliculitis barbae and groin
  • Pregnant and lactating

About Azidus Brasil

Azidus Brasil is a leading clinical research organization specializing in the development and management of clinical trials across various therapeutic areas. With a commitment to advancing healthcare, Azidus Brasil leverages its expertise in regulatory affairs, data management, and patient recruitment to deliver high-quality, efficient clinical study solutions. The organization collaborates with pharmaceutical and biotechnology companies to facilitate the successful progression of innovative therapies from initial research through to market authorization, ensuring adherence to the highest standards of ethics and scientific rigor.

Locations

Valinhos, Sp, Brazil

Patients applied

0 patients applied

Trial Officials

Alexandre Frederico, médico

Principal Investigator

Azidus Brasil

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials